Satsuma Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Satsuma Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q1 2023.
  • Satsuma Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $82K, a 66.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $82K -$162K -66.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $108K Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $154K Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $199K Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $244K Mar 31, 2022 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.